Search results for "arki"

showing 10 items of 1015 documents

Drosophila DJ-1 mutants are sensitive to oxidative stress and show reduced lifespan and motor deficits.

2007

Parkinson's disease (PD) is a progressive movement disorder caused by the selective and massive loss of dopaminergic neurons (DA) in the substantia nigra pars compacta (SNc). DJ-1 loss-of-function mutations are involved in inherited early-onset PD forms and result in dysfunction of the oxidative stress response. In mice models, DJ-1 loss provokes sensitivity to oxidative insults but does not produce neurodegeneration. Similar results have been found when analyzing Drosophila mutants for the DJ-1 orthologous genes, DJ-1alpha and DJ-1beta. Here, we report the analysis of two new mutations for the Drosophila DJ-1 genes. Both ubiquitous induction of DJ-1alpha knockdown by RNAi and loss of funct…

Parkinson's diseaseDopamineProtein Deglycase DJ-1Substantia nigraNerve Tissue ProteinsBiologyMotor Activitymedicine.disease_causeLife ExpectancyGeneticsmedicineAnimalsDrosophila ProteinsLoss functionNeuronsGene knockdownPars compactaNeurodegenerationAge FactorsGeneral MedicineAnatomymedicine.diseaseCell biologyOxidative Stressmedicine.anatomical_structureMutationRNA InterferenceNeuronOxidative stressGene
researchProduct

Nitric oxide modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders.

2011

Several recent studies have emphasized a crucial role for the nitrergic system in movement control and the pathophysiology of the basal ganglia (BG). These observations are supported by anatomical evidence demonstrating the presence of nitric oxide synthase (NOS) in all the basal ganglia nuclei. In fact, nitrergic terminals have been reported to make synaptic contacts with both substantia nigra dopamine-containing neurons and their terminal areas such as the striatum, the globus pallidus and the subthalamus. These brain areas contain a high expression of nitric oxide (NO)-producing neurons, with the striatum having the greatest number, together with important NO afferent input. In this pape…

Parkinson's diseaseMovement disordersSubstantia nigraStriatumNitric OxideSettore BIO/09 - FisiologiaBasal GangliaBasal Ganglia DiseasesBasal gangliamedicineAnimalsHumansMovement disordersPharmacologyMovement Disordersbusiness.industryGeneral NeuroscienceNITRIC OXIDE BASAL GANGLIASubthalamusNitric oxideParkinson Diseasemedicine.diseasemedicine.anatomical_structureGlobus pallidusnervous systemDyskinesiaBasal gangliaParkinson’s diseasemedicine.symptomNerve NetbusinessNeuroscienceCNSneurological disorders drug targets
researchProduct

G2019S Variation in LRRK2: An Ideal Model for the Study of Parkinson's Disease?

2019

Parkinson’s disease (PD) is the second most common neurodegenerative disorder and has plagued humans for more than 200 years. The etiology and detailed pathogenesis of PD is unclear, but is currently believed to be the result of the interaction between genetic and environmental factors. Studies have found that PD patients with the LRRK2:G2019S variation have the typical clinical manifestations of PD, which may be familial or sporadic, and have age-dependent pathogenic characteristics. Therefore, the LRRK2:G2019S variation may be an ideal model to study the interaction of multiple factors such as genetic, environmental and natural aging factors in PD in the future. This article reviewed the …

Parkinson's diseaseNatural agingDiseaseReviewBioinformatics050105 experimental psychologylcsh:RC321-57103 medical and health sciencesBehavioral Neuroscience0302 clinical medicineG2019s mutationG2019S mutationmedicine0501 psychology and cognitive scienceslcsh:Neurosciences. Biological psychiatry. NeuropsychiatryBiological Psychiatrybusiness.industrydisease modelpathogenesis05 social sciencesLRRK2medicine.diseaseLRRK2nervous system diseasesPsychiatry and Mental healthNeuropsychology and Physiological PsychologyMultiple factorsVariation (linguistics)NeurologyEtiologyParkinson’s diseasebusiness030217 neurology & neurosurgeryNeuroscienceFrontiers in human neuroscience
researchProduct

Neural networks engaged in milliseconds and seconds time processing: evidence from transcranial magnetic stimulation and patients with cortical or su…

2009

Here, we review recent transcranial magnetic stimulation studies and investigations in patients with neurological disease such as Parkinson's disease and stroke, showing that the neural processing of time requires the activity of wide range-distributed brain networks. The neural activity of the cerebellum seems most crucial when subjects are required to quickly estimate the passage of brief intervals, and when time is computed in relation to precise salient events. Conversely, the circuits involving the striatum and the substantia nigra projecting to the prefrontal cortex (PFC) are mostly implicated in supra-second time intervals and when time is processed in conjunction with other cognitiv…

Parkinson's diseaseNerve netParkinson's diseaseRepetitive transcranial magnetic stimulationmedicine.medical_treatmentParkinson's disease; Repetitive transcranial magnetic stimulation; Stroke; Time perception; Timing; Transcranial magnetic stimulation;Time perceptionReviewGeneral Biochemistry Genetics and Molecular BiologyNOStimulus modalityCerebral Cortex; Humans; Time Perception; Brain Diseases; Transcranial Magnetic Stimulation; Nerve NetmedicineHumansTimingBRAINPrefrontal cortexCerebral CortexBrain DiseasesSettore M-PSI/02 - Psicobiologia E Psicologia Fisiologicabusiness.industryCognitionTime perceptionmedicine.diseaseTIMEStrokeTranscranial magnetic stimulationmedicine.anatomical_structureCerebral cortexSettore MED/26 - NeurologiaNerve NetGeneral Agricultural and Biological SciencesbusinessNeuroscienceTranscranial magnetic stimulationPhilosophical Transactions of the Royal Society B: Biological Sciences
researchProduct

Genetic epidemiology of Parkinson's disease

2004

Parkinson's diseaseNeurologyPlant disease epidemiologyMolecular epidemiologyGenetic epidemiologybusiness.industryMedicineNeurology (clinical)businessBioinformaticsmedicine.diseaseRevue Neurologique
researchProduct

Gender Effect on Parkinson’s disease

2009

Parkinson's diseaseSettore MED/26 - Neurologiawomen
researchProduct

Imaging of Substantia Nigra in Parkinson's Disease: A Narrative Review.

2021

Parkinson’s disease (PD) is a progressive neurodegenerative disorder, characterized by motor and non-motor symptoms due to the degeneration of the pars compacta of the substantia nigra (SNc) with dopaminergic denervation of the striatum. Although the diagnosis of PD is principally based on a clinical assessment, great efforts have been expended over the past two decades to evaluate reliable biomarkers for PD. Among these biomarkers, magnetic resonance imaging (MRI)-based biomarkers may play a key role. Conventional MRI sequences are considered by many in the field to have low sensitivity, while advanced pulse sequences and ultra-high-field MRI techniques have brought many advantages, partic…

Parkinson's diseaseSettore MED/50 - Scienze Tecniche Mediche ApplicateSubstantia nigraNeurosciences. Biological psychiatry. NeuropsychiatryDiseaseStriatumReview030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineironneurodegenerative diseasemedicinemagnetic resonance imagingneurodegenerative diseasesmedicine.diagnostic_testPars compactabusiness.industryGeneral NeuroscienceradiomicSettore MED/37 - NeuroradiologiabiomarkersMagnetic resonance imagingmedicine.diseaseparkinsonian disordersnigrosome-1radiomicsParkinson’s diseasebiomarkerSettore MED/26 - NeurologiaDifferential diagnosisneuromelaninbusinessSettore MED/36 - Diagnostica Per Immagini E RadioterapiaNeuroscience030217 neurology & neurosurgeryDiffusion MRIRC321-571Brain sciences
researchProduct

Non-steroidal anti-inflammatory drugs in Parkinson’s disease

2007

Parkinson's disease (PD) is known to be a chronic and progressive neurodegenerative disease caused by a selective degeneration of dopaminergic (DAergic) neurons in the substantia nigra pars compacta (SNc). A large body of experimental evidence indicates that the factors involved in the pathogenesis of this disease are several, occurring inside and outside the DAergic neuron. Recently, the role of the neuron–glia interaction and the inflammatory process, in particular, has been the object of intense study by the research community. It seems to represent a new therapeutic approach opportunity for this neurological disorder. Indeed, it has been demonstrated that the cyclooxygenase type 2 (COX-…

Parkinson's diseaseSubstantia nigraParkinson's DeseaseNeuroprotectionSettore BIO/09 - FisiologiaCyclooxygenase inhibitorschemistry.chemical_compoundDevelopmental NeuroscienceDopamineMedicineHumansNervous system -- DiseasesAgedInflammationHydroxydopaminebusiness.industryPars compactaMPTPDopaminergicAnti-Inflammatory Agents Non-SteroidalParkinson DiseaseParkinson's disease -- TreatmentMiddle Agedmedicine.diseaseNeuroprotective AgentsNeurologychemistrynervous systembusinessNeuroscienceNervous system -- Degenerationmedicine.drug
researchProduct

Impact of Parkinson?s disease on the efficiency of masticatory cycles : electromyographic analysis

2019

Background This study evaluated the efficiency of masticatory cycles by means of the linear envelope of the electromyographic signal of the masseter and temporalis muscles in individuals with Parkinson’s disease. Material and Methods Twenty-four individuals were assigned into two groups: with Parkinson’s disease, average ± SD 66.1 ± 3.3 years (n = 12) and without the disease, average ± SD: 65.8 ± 3.0 years (n = 12). The MyoSystem-I P84 electromyograph was used to analyze the activity of masticatory cycles through the linear envelope integral in habitual mastication of peanuts and raisins and non-habitual mastication of Parafilm M®. Results There was statistically significant difference (P ≤…

Parkinson's diseaseTemporal MuscleElectromyographyTemporal muscleMasseter muscle03 medical and health sciences0302 clinical medicinemedicineHumansGeneral DentistryMasticationOrthodonticsOral Medicine and Pathologymedicine.diagnostic_testElectromyographic analysisbusiness.industryElectromyographyMasseter MuscleResearchParkinson Disease030206 dentistryRight masseter muscle:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseMasticatory forceOtorhinolaryngologyMASTIGAÇÃOUNESCO::CIENCIAS MÉDICASMasticationSurgerybusiness
researchProduct

Drosophila Models of Parkinson's Disease: Discovering Relevant Pathways and Novel Therapeutic Strategies

2010

Parkinson's disease (PD) is the second most common neurodegenerative disorder and is mainly characterized by the selective and progressive loss of dopaminergic neurons, accompanied by locomotor defects. Although most PD cases are sporadic, several genes are associated with rare familial forms of the disease. Analyses of their function have provided important insights into the disease process, demonstrating that three types of cellular defects are mainly involved in the formation and/or progression of PD: abnormal protein aggregation, oxidative damage, and mitochondrial dysfunction. These studies have been mainly performed in PD models created in mice, fruit flies, and worms. Among them, Dro…

Parkinson's diseasebiologyved/biologyved/biology.organism_classification_rank.speciesDopaminergicNeuroscience (miscellaneous)Review ArticleDiseasebiology.organism_classificationmedicine.diseaseBioinformaticslcsh:RC346-429PathogenesisPsychiatry and Mental healthmedicineNeurology (clinical)Model organismDrosophilaGenelcsh:Neurology. Diseases of the nervous systemFunction (biology)Parkinson's Disease
researchProduct